mk-0616
merck
['cardio']
. &amp; i discuss the efficacy and safety of the oral pcsk9 inhibitor mk-0616 and how the outcomes from this phase 2 rct can lower ldl-c in patients with hypercholesterolemia #acc23 #wccardio #accesspoints 
Non-Profit Founder/Leader | ❤️ Doc | Artist | Scientist | Educator | News Anchor https://t.co/7OIKCgMVAT | RT ≠ endorse | Disclaimer: https://t.co/bwmE2O3U5W